DEVELOPMENT OF NOVEL THERAPEUTIC APPROACHES FOR BREAST CANCERS HARBORING PIK3CA MUTATIONS

$631,577FY2012Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators